Editorial: Induced Pluripotent Stem Cell-Based Disease Modeling and Drug Discovery: Can We Recapitulate Cardiovascular Disease on a Culture Dish?

Front Cell Dev Biol. 2022 Jan 31:9:831304. doi: 10.3389/fcell.2021.831304. eCollection 2021.

Shinsuke Yuasa¹, Masayuki Yazawa^{2

3

4}, Jong-Kook Lee⁵

¹ Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
² Department of Rehabilitation and Regenerative Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY, United States.
³ Department of Molecular Pharmacology and Therapeutics, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY, United States.
⁴ Columbia Stem Cell Initiative, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY, United States.
⁵ Department of Cardiovascular Regenerative Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

No abstract available

Keywords: cardiomyocyte; disease modeling; drug discovery; endothelial cell; iPS cell.

Publication types